Financial Consequences of the Act on Reimbursement of Medicines for the National Health Fund and Patients (Finansowe konsekwencje ustawy o refundacji lekow dla Narodowego Funduszu Zdrowia i pacjentow)

Zofia Skrzypczak () and Jadwiga Suchecka ()
Additional contact information
Zofia Skrzypczak: Faculty of Management, University of Warsaw
Jadwiga Suchecka: Medical University of Lodz, Faculty of Health Sciences, Department of Medical Insurance and Health Care Financing.

Problemy Zarzadzania, 2018, vol. 16, issue 78, 35-50

Abstract: The aim of the paper is to present the financial consequences of the entry into force of the Reimbursement Act in 2012 for the National Health Fund, a payer of public funds, and for individual patients. A greater burden on the society – i.e. an increase in the level of co-payment for medicines – turns out to be integrated in the general tendency that emerges during the economic crisis in many European countries at different levels of socio-economic development.

Keywords: total pharmaceutical expenditure; out-of-pocket expenditure; reimbursement of medicines (search for similar items in EconPapers)
JEL-codes: I11 I15 I18 (search for similar items in EconPapers)
Date: 2018
References: Add references at CitEc
Citations:

Downloads: (external link)
https://press.wz.uw.edu.pl/ems/vol16/iss78/3 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sgm:pzwzuw:v:16:i:78:y:2018:p:35-50

Access Statistics for this article

More articles in Problemy Zarzadzania from University of Warsaw, Faculty of Management Contact information at EDIRC.
Bibliographic data for series maintained by ().